You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

relapse after allogeneic transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and

Completed
  • Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
    • Roma, Italy
      Servizio E Dh Di Ematologia
    Feb 23, 2023

    Acute Myeloid Leukemia Trial (Azacitidine, Donor lymphocyte infusion, Camrelizumab)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Mar 15, 2023

    Digital Droplet PCR in Early Period After Allo-HSCT to Predict

    Completed
    • Measurable Residual Disease
    • Digital Droplet PCR
    • Hangzhou, Zhejiang, China
      The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
    Aug 17, 2023

    Multiple Myeloma Trial in Hamburg (allogeneic HSCT)

    Completed
    • Multiple Myeloma
    • allogeneic HSCT
    • Hamburg, Germany
      University Medical Center Hamburg-Eppendorf
    Sep 1, 2022

    Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

    Not yet recruiting
    • Multiple Myeloma
    • Allogeneic Stem Cell Transplantation
    • CARTemis-1
    • Santander, Cantabria, Spain
    • +4 more
    Aug 1, 2023

    Acute Myeloid Leukemia Trial in Hefei (RC1012 injection (allo-DNT cells))

    Recruiting
    • Acute Myeloid Leukemia
    • RC1012 injection (allo-DNT cells)
    • Hefei, Anhui, China
      The First Hospital of the University of Science and Technology o
    May 17, 2023

    Acute Myeloid Leukemia (AML) Relapse Trial in Freiburg, Münster (F16IL2, BI 836858)

    Completed
    • Acute Myeloid Leukemia (AML) Relapse
    • Freiburg, Germany
    • +1 more
    Apr 13, 2022

    Recurrent Acute Myeloid Leukemia Trial in Nashville (Venetoclax, Decitabine, Cedazuridine)

    Not yet recruiting
    • Recurrent Acute Myeloid Leukemia
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Mar 22, 2023

    Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia Trial in Chicago (Pembrolizumab)

    Recruiting
    • Classical Hodgkin Lymphoma
    • +3 more
    • Chicago, Illinois
      University of Chicago
    Jun 29, 2021

    Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Guanzhou, Guandong, China
      Nanfang Hospital of Southern Medical University
    Mar 6, 2022

    Adult Acute Myeloid Leukemia in Remission, Recurrent Adult Acute Myeloid Leukemia Trial in Aurora, Columbus (PF-04449913)

    Completed
    Has Results
    • Adult Acute Myeloid Leukemia in Remission
    • Recurrent Adult Acute Myeloid Leukemia
    • Aurora, Colorado
    • +1 more
    Dec 30, 2021

    Leukemia, Myeloid, Acute Trial in France (Ponatinib 30 MG)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Ponatinib 30 MG
    • Angers, France
    • +13 more
    Aug 4, 2021

    Acute Lymphoblastic Leukemia, in Relapse Trial in Bergamo, Monza (CARCIK-CD19)

    Active, not recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • CARCIK-CD19
    • Bergamo, BG, Italy
    • +1 more
    Feb 3, 2022

    Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)

    Not yet recruiting
    • Acute Graft Versus Host Disease
    • Hematopoietic and Lymphoid System Neoplasm
    • Fecal Microbiota Transplantation Capsule
    • Placebo
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Sep 6, 2023

    Acute Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial (Siremadlin)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Stem Cell Transplantation
    • Tel Aviv, Israel
    • +2 more
    Jan 23, 2023

    AML/MDS Trial in Copenhagen (iDLI)

    Recruiting
    • AML/MDS
    • iDLI
    • Copenhagen, Denmark
      Copenhagen University Hospital, Rigshospitalet
    Jan 13, 2023

    Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

    Active, not recruiting
    • Hematologic Malignancy
    • Milwaukee, Wisconsin
      Froedtert Hospital
    Jan 31, 2023

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

    Recruiting
    • Hematopoietic Malignancy
    • +2 more
    • Umbilical Cord Blood Transplantation
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow university
    Nov 6, 2023

    Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Allogeneic Stem Cell Transplantation Trial in United States

    Recruiting
    • Acute Myeloid Leukemia
    • +2 more
    • Boston, Massachusetts
    • +5 more
    Oct 21, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Duarte, California
      City of Hope Medical Center
    Apr 10, 2023

    Hematologic Tumors Trial run by the NCI (donor lymphocyte infusion, Cyclophosphamide, Busulfan)

    Suspended
    • Hematologic Neoplasms
    • donor lymphocyte infusion
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 30, 2022

    Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

    Completed
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 4, 2023

    Leukemia, Graft Failure Trial in Lille (eltrombopag)

    Recruiting
    • Leukemia
    • Graft Failure
    • Lille, France
      Hôpital Claude Huriez, CHU
    Aug 18, 2022

    Relapse Rate After Allo-HSCT Trial in Shanghai (Flu-Bu-Mel)

    Active, not recruiting
    • Relapse Rate After Allo-HSCT
    • Shanghai, China
    • +1 more
    Jun 1, 2021

    Acute Myeloid Leukemia, High Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial in Moscow (boost

    Recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • boost anti-viral immunity after T-cell depleted HSCT
    • Moscow, Russian Federation
      Federal Research Center for pediatric hematology, oncology and i
    Oct 1, 2021